Your browser doesn't support javascript.
loading
Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study.
Gudmundsdottir, Valborg; Pedersen, Helle Krogh; Mazzoni, Gianluca; Allin, Kristine H; Artati, Anna; Beulens, Joline W; Banasik, Karina; Brorsson, Caroline; Cederberg, Henna; Chabanova, Elizaveta; De Masi, Federico; Elders, Petra J; Forgie, Ian; Giordano, Giuseppe N; Grallert, Harald; Gupta, Ramneek; Haid, Mark; Hansen, Torben; Hansen, Tue H; Hattersley, Andrew T; Heggie, Alison; Hong, Mun-Gwan; Jones, Angus G; Koivula, Robert; Kokkola, Tarja; Laakso, Markku; Løngreen, Peter; Mahajan, Anubha; Mari, Andrea; McDonald, Timothy J; McEvoy, Donna; Musholt, Petra B; Pavo, Imre; Prehn, Cornelia; Ruetten, Hartmut; Ridderstråle, Martin; Rutters, Femke; Sharma, Sapna; Slieker, Roderick C; Syed, Ali; Tajes, Juan Fernandez; Thomas, Cecilia Engel; Thomsen, Henrik S; Vangipurapu, Jagadish; Vestergaard, Henrik; Viñuela, Ana; Wesolowska-Andersen, Agata; Walker, Mark; Adamski, Jerzy; Schwenk, Jochen M.
Afiliação
  • Gudmundsdottir V; Department of Bio and Health Informatics, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Pedersen HK; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Mazzoni G; Department of Bio and Health Informatics, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Allin KH; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Artati A; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Beulens JW; Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark.
  • Banasik K; Research Unit Molecular Endocrinology and Metabolism, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg, Germany.
  • Brorsson C; Amsterdam UMC, location VUmc, Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Cederberg H; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Chabanova E; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • De Masi F; Department of Bio and Health Informatics, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Elders PJ; Department of Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland.
  • Forgie I; Department of Diagnostic Radiology, Copenhagen University Hospital Herlev Gentofte, Herlev, Denmark.
  • Giordano GN; Department of Bio and Health Informatics, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Grallert H; Amsterdam UMC, location VUmc, Department of General Practice, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Gupta R; Population Health & Genomics, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK.
  • Haid M; Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Hansen T; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
  • Hansen TH; Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.
  • Hattersley AT; Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München and Ludwig-Maximilians Universität München, Munich, Germany.
  • Heggie A; Clinical Cooperation Group Nutrigenomics and Type 2 Diabetes, Helmholtz Zentrum München and Technische Universität München, Munich, Germany.
  • Hong MG; Department of Bio and Health Informatics, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Jones AG; Novo Nordisk Research Centre Oxford, Oxford, UK.
  • Koivula R; Research Unit Molecular Endocrinology and Metabolism, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg, Germany.
  • Kokkola T; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Laakso M; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Løngreen P; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Mahajan A; Department of Cardiology and Endocrinology, Slagelse Hospital, Slagelse, Denmark.
  • Mari A; The Institute of Clinical and Biological Sciences, University of Exeter College of Medicine and Health, University of Exeter, Exeter, UK.
  • McDonald TJ; Institute of Cellular Medicine (Diabetes), Newcastle University, Newcastle upon Tyne, UK.
  • McEvoy D; Affinity Proteomics, Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of Technology, Solna, Sweden.
  • Musholt PB; The Institute of Clinical and Biological Sciences, University of Exeter College of Medicine and Health, University of Exeter, Exeter, UK.
  • Pavo I; Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Prehn C; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK.
  • Ruetten H; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland.
  • Ridderstråle M; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland.
  • Rutters F; Department of Bio and Health Informatics, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Sharma S; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Slieker RC; Institute of Neurosciences, National Research Council, Padova, Italy.
  • Syed A; NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, UK.
  • Tajes JF; Institute of Cellular Medicine (Diabetes), Newcastle University, Newcastle upon Tyne, UK.
  • Thomas CE; Sanofi, Diabetes Division, Research and Development, Frankfurt, Germany.
  • Thomsen HS; Eli Lilly Regional Operations GmbH, Vienna, Austria.
  • Vangipurapu J; Research Unit Molecular Endocrinology and Metabolism, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg, Germany.
  • Vestergaard H; Sanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany.
  • Viñuela A; Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Wesolowska-Andersen A; Novo Nordisk A/S, Søborg, Denmark.
  • Walker M; Amsterdam UMC, location VUmc, Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Adamski J; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
  • Schwenk JM; Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.
Genome Med ; 12(1): 109, 2020 12 01.
Article em En | MEDLINE | ID: mdl-33261667
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Diabetes Mellitus Tipo 2 / Transcriptoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genome Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Diabetes Mellitus Tipo 2 / Transcriptoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genome Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca